News & Publications

Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment

Anthony V. Lemmo, CEO of BioDot discusses the demand for COVID-19 tests and the diagnostic manufacturing communities ability to scale-up production.

Contact Us
Download PDF
Download PDF
Contact Us
View Article
Contact Us
Contact Us
Contact Us
View Event
Contact Us
Contact Us
Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment
Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment
Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment
Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment
Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment
Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate InvestmentBarron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment
Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment
Journey of The Dot| Blotting a Course to Rapid Allergy Diagnostic Test Manufacturing
Omnia™ Discovery Data Sheet
Omnia™ Discovery FAQs
Journey of The Dot| Enhancing Autoimmune Disease Diagnostics with Advanced Dispensing Technology
Journey of The Dot| 30 Years of Making a Difference
Application Support and Service
IQ/OQ
Preventative Maintenance Plans
Remote Support
Service Level Agreements
Warranty
Comprehensive Service Guide
Year-End Promo Flyer
Sphera™ Discovery Datasheet
Sphera™ Discovery FAQs
Sphera™ Discovery Special Offer
Sphera™ Discovery Brochure
The Dot
Biochip/biosensor Flyer
Interview on Omnia™
Microarray Flyer
MODULIS Webinar
Cell Dispensing Flyer
BioDot's Low Volume PCR Offerings
BioDot CellWriter S Application Note
MODULIS™ FAQs
MODULIS™ Factsheet
MODULIS™ Data Sheet
MODULIS™ Press Release
MODULIS™ White Paper
CellWriter™S Consumables Brochure
EOL/EOS FAQs
Five Direct Titration Headaches You Can Totally Eliminate Right Now
BioDot OEM Brochure
Customer Interview- Cytogenetics
Lyophilized Beads: Efficient, Scalable Production
Validation and implementation of BioDot instruments for semi-automated FISH slide processing
Biosensor Manufacturing Brochure
Low Volume Dispensing for R&D and Manufacturing
AD1520
AD6020
Rainmaker Data Sheet
AD3200
CM5000 Data Sheet
AR3000
LM5000
RR120 Flyer
LM9000
XYZ Batch Dispensing Flyer
BioDot Open House Agenda
FISH - A Fast and Inexpensive Tool for Cytogenetics
Single-Droplet Microsensor for Ultra-Short Circulating Tumor EFGR Mutation Detection in Lung Cancer Based on Multiplex EFIRM Liquid Biopsy
CellWriter S Data Sheet
Lateral Flow Test Manufacturing
Lateral Flow Workshop Flyer
Rainmaker™
Sphera Webinar
Omnia™ Data sheet
Sphera™ Data Sheet
Lyobead Application Note 1
Lyobead Application Note 2
Omnia Press Release
EOL/EOS Notification
Lab on a Chip & Microfluidics Europe 2022
Comparing FISHArray low volume multi-welled slides to manually prepared FISH slides
The New FISH: Welcome to Cytogenetics 2.0
BioDot Accelerates Customer Innovation Through Acquisition by ATS Automation
Dip Coating vs. AirJet - LF Conjugate, Application Note
BioDot PolyJet™: Dispensing Surface Mount Epoxy with Different Size Drops
In Line Array Dispensing System with Lamination and Vision Inspection
ATS Acquires Fluid Dispensing & Laboratory Automation Equipment Provider BioDot Inc.
A worrying decline in COVID testing
Healthcare de Jure host Matthew Fisher speaks with BioDot CEO Tony Lemmo about diagnostic testing
Using Rapid Antigen Tests To Fight SARS-CoV-2
BioDot PolyJet™ Dispensing Mineral Oil into Microwells
BioDot Welcomes Debbie Bowers as Senior Vice President of Commerical Development
What if you test positive for covid-19 abroad? Here’s what travelers need to know.
The Greatest Lesson Learned from COVID-19 Pandemic
BioDot technology helping Covid-19 test manufacturers meet demands
Considerations for scaling assays in life science
Biosensor Production System Pick And Place 3 Sheet Positions
PE-Backed BioDot Finds Calling in Eventful 2020
US Plans for hundreds of millions of cheap, fast COVID-19 tests
Despite Greater Demand from Nursing homes, Dx Firms Confident about COVID-19 Rapid Testing Capacity
Calmark announces development of LDH test for assessment of Covid-19
Automated Lamination for Lateral Flow Device Manufacturing
CM5000 with Bottle Collection
Conveyor Based Dispensing Systems for Diagnostic Test Manufacturing
Congratulations to Abingdon Health on their COVID-19 rapid antibody test.
Barron's Article - Covid-19 Test Demand Will Break Global Capacity Without Immediate Investment
BioDot's Rainmaker technology used at Draper to develop custom miniaturized microarrays
Antibody tests can yield false positives, especially where infection rates are relatively low
VP5010/5020 Vacuum Pump
BioDot Accelerates Manufacturing to Help Customers Meet Global COVID-19 Testing Demand
BioDot Supports COVID-19 Test Manufacturers Globally
BioDot Response to COVID-19
Need for Rapid COVID-19 Tests
BioDot Acquired by Artemis
COVID-19 Rapid Test Manufacturing
Multiplex Array Web Printing for Lateral Flow Devices
Prev Resource
Next Resource

Related Products

No items found.
No items found.
No items found.